A Study to Evaluate the Safety and Immunogenicity of Booster With AZD1222, mRNA-1273, or MVC-COV1901 Against COVID-19

Clinical trial NCT05197153 · COMPLETED

Trial details

NCT number: NCT05197153
Sponsor: Medigen Vaccine Biologics Corp.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

COVID-19 Vaccine

Start date: 2022-01-22
Primary completion: 2022-06-01
Enrollment: 804

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.